Robert Lai

A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer’s disease with lecanemab, an anti-Aβ protofibril antibody

Chad J. Swanson, Yong Zhang, Shobha Dhadda et al. · Alzheimer s Research & Therapy · 2021 · 757 citations · Full text

Selective inhibition of Alzheimer disease-like tau aggregation by phenothiazines.

Claude M. Wischik, Patricia C. Edwards, Robert Lai et al. · Proceedings of the National Academy of Sciences · 1996 · 532 citations · Full text

Protein Assembly, Molecular Biology, Neurochemical Biomarkers +18

Safety and tolerability of BAN2401 - a clinical study in Alzheimer’s disease with a protofibril selective Aβ antibody

Veronika Logovinsky, Andrew Satlin, Robert Lai et al. · Alzheimer s Research & Therapy · 2016 · 278 citations · Full text

The effects of the TRPV1 antagonist SB-705498 on TRPV1 receptor-mediated activity and inflammatory hyperalgesia in humans

Boris A. Chizh, M. O'Donnell, Antonella Napolitano et al. · Pain · 2007 · 244 citations

Clinical trial of the p38 MAP kinase inhibitor dilmapimod in neuropathic pain following nerve injury

Praveen Anand, Ravikiran Shenoy, Joanne Palmer et al. · European Journal of Pain · 2011 · 166 citations

Pain Therapy, Pain Medicine, Neuropathic Pain +18